Document Detail


Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants.
MedLine Citation:
PMID:  9329422     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The influence of topical iodine-containing antiseptics on thyroid function test results of premature infants was determined in two separate studies. Thyroxine and thyrotropin levels were measured on blood-spotted filter paper. Samples were obtained from 128 premature infants on their tenth day of life; the infants were treated in two neonatal intensive care units. Both units used similar treatment protocols; however, one routinely used topical iodinated antiseptic agents (n = 73), whereas the other used chlorhexidine-containing antiseptics (n = 55). There was no difference in the mean T4 levels between the two groups. The mean thyrotropin levels were elevated in preterm babies exposed to iodine (15.4 vs 7.8 mIU/L, p < 0.01). Among the iodine-exposed infants, elevated thyrotropin levels (> 30 mIU/L) were found in 13.7% of infants, compared with none in the chlorhexidine-treated group (p < 0.01). We then studied an additional 46 premature infants who were treated in one neonatal intensive care unit. Iodine-containing solutions were used in 24 infants and chlorhexidine was used in 22 infants. T4 and thyrotropin levels were measured weekly during the first 28 days, one every 2 weeks until the age of 60 days, and at the age of 90 days. Among iodine-exposed infants, 20.8% had thyrotropin values > 30 mIU/L, whereas none of the infants in the chlorhexidine group had elevated thyrotropin values (p < 0.05). The elevated thyrotropin levels correlated positively with the area of disinfection. Elevated urine iodine levels were present reflecting an abnormally high iodine absorption. This study suggests that iodine absorption from topical iodine-containing antiseptics may cause disturbances in thyroid function test results in premature infants. We recommend that caution be exercised in the use of iodine-containing antiseptics in premature infants.
Authors:
N Linder; N Davidovitch; B Reichman; J Kuint; D Lubin; J Meyerovitch; B A Sela; Z Dolfin; J Sack
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  131     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1997 Sep 
Date Detail:
Created Date:  1997-10-30     Completed Date:  1997-10-30     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  434-9     Citation Subset:  AIM; IM    
Affiliation:
Department of Neonatology, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Infective Agents, Local / adverse effects*,  urine
Chlorhexidine / analogs & derivatives*,  therapeutic use
Cross-Over Studies
Female
Humans
Hypothyroidism / chemically induced*,  metabolism
Infant
Infant, Newborn
Infant, Premature, Diseases / chemically induced*,  metabolism
Intensive Care, Neonatal
Male
Povidone-Iodine / adverse effects*
Retrospective Studies
Thyrotropin / blood
Thyroxine / blood
Chemical
Reg. No./Substance:
0/Anti-Infective Agents, Local; 25655-41-8/Povidone-Iodine; 55-56-1/Chlorhexidine; 7488-70-2/Thyroxine; 9002-71-5/Thyrotropin; MOR84MUD8E/chlorhexidine gluconate
Comments/Corrections
Comment In:
J Pediatr. 1998 Aug;133(2):309-10   [PMID:  9709732 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human development index as a predictor of infant and maternal mortality rates.
Next Document:  Very long chain acyl-coenzyme A dehydrogenase deficiency in two siblings: evolution after prenatal d...